Next up.

Next-gen sequencing performed on blood samples from 24 patients on the day of their curative intent resection of oligometastatic colorectal cancer detected residual molecular disease with pretty perfect sensitivity and specificity and even revealed candidacy for immune checkpoint inhibition or targeted therapies. | Pellini, JCO Precis Oncol 2021

Comments

Popular Posts